Agency for Healthcare Research and Quality.

For MDD patients with 2 or more antidepressant treatment failures, rTMS is a reasonable, effective consideration.

There is substantial variation in survivorship care models. The optimal nature, timing, intensity, format, and outcomes of survivorship care models are uncertain and require further research. Specific research questions need to be addressed by the survivorship community to better understand the advantages and limitations of survivorship models.

No abstract

No abstract